TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Xellia Pharmaceuticals ApS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 301,938 | 241,064 | 274,554 |
Earnings before taxes | -34,238 | -59,168 | -18,356 |
Total assets | 465,318 | 502,091 | 549,902 |
Current assets | 144,009 | 176,139 | 229,433 |
Current liabilities | 147,308 | 122,177 | 92,925 |
Equity capital | 235,423 | 280,077 | 352,317 |
- share capital | 27,030 | 27,030 | 27,018 |
Employees (average) | 350 | 350 | 350 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 50.6% | 55.8% | 64.1% |
Turnover per employee | 863 | 689 | 784 |
Profit as a percentage of turnover | -11.3% | -24.5% | -6.7% |
Return on assets (ROA) | |||
Current ratio | 97.8% | 144.2% | 246.9% |
Return on equity (ROE) | -14.5% | -21.1% | -5.2% |
Change turnover | 60,874 | -33,604 | -40,834 |
Change turnover % | 25% | -12% | -13% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.